Is There an Azstarys Shortage?
Azstarys is a prescription drug used to treat ADHD. Some ADHD medications have recently been in short supply. Learn whether Azstarys is affected and how to check its availability.
Azstarys is not currently listed in the Food and Drug Administration (FDA) drug shortages database. Here's what to know about why some ADHD medications may be hard to find and how to check for drug shortages.
Is there a shortage of other ADHD drugs?
In recent years, several ADHD medications have been in short supply. A few examples include Adderall, Concerta, Ritalin, and Vyvanse. It's not yet clear when these shortages will fully resolve.
These shortages have affected both brand-name and generic versions of the drugs. As a result, some people have worked with their doctor to switch to a different medication or adjust their ADHD treatment plan.
To check the current status of Aztarys and other ADHD medications, visit the FDA drug shortages website.
How do ADHD drug shortages affect people?
Shortages of ADHD medications can make it harder for people to stick with their treatment plan. This can cause ADHD symptoms to return or become more difficult to manage. A lack of consistent access to ADHD medication may also increase stress and affect mental health.
Other possible effects of disrupted access to ADHD medication include:
difficulty focusing or completing daily tasks
increased impulsivity or emotional outbursts
difficulty falling or staying asleep
withdrawing from social, family, or work activities
If you're having trouble filling a prescription for an ADHD medication, talk with your doctor or pharmacist. They may recommend alternatives or adjust your treatment plan based on what's available.
What causes a drug shortage?
Several factors can lead to a medication being in short supply. Common causes of ADHD drug shortages include:
Increased demand: More people receiving diagnoses of ADHD have led to greater demand for medications. This can strain manufacturers and reduce availability at pharmacies.
Regulatory limits: Stimulant medications used to treat ADHD, including Azstarys, are controlled substances. The Drug Enforcement Administration (DEA) sets yearly production limits for these medications. If demand rises suddenly, these limits may contribute to shortages.
Supply chain issues: Shortages of raw materials, packaging supplies, or labor can delay the manufacturing and availability of ADHD drugs.
When multiple ADHD medications are in short supply at the same time, it can be especially hard for pharmacies to keep any option in stock. Even when generic forms are available, they may be affected by the same issues as brand-name drugs. As a result, generics may be just as difficult to find during a shortage.
How can I check whether Azstarys is available near me?
Azstarys is not currently listed by the FDA as being in shortage. However, some people may still experience delays when trying to fill their prescription. Availability can vary depending on your pharmacy, location, and insurance plan.
If you're having trouble finding Azstarys, start by talking with a pharmacist. If possible, visit the pharmacy in person. Some pharmacies may not share inventory details for ADHD medications over the phone.
You can also check pharmacy websites or apps, which sometimes offer tools to look up availability online. Keep in mind that availability may change as new shipments arrive.
You can also check with your insurance provider. If Azstarys isn't available through your plan's preferred pharmacy, your insurer may be able to help you locate another pharmacy.
In some cases, you may want to reach out to the drug manufacturer for information about availability in your area. To learn more about contacting the manufacturer, visit the Azstarys website.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
38 minutes ago
- Washington Post
New York lawmakers approve bill that would allow medically assisted suicide for the terminally ill
ALBANY, N.Y. — Terminally ill New Yorkers would have the legal ability to end their own lives with pharmaceutical drugs under a bill passed Monday in the state Legislature. The proposal, which now moves to the governor's office, would allow a person with an incurable illness to be prescribed life-ending drugs if he or she requests the medication and gets approval from two physicians. A spokesperson for New York Gov. Kathy Hochul said she would review the legislation.
New York Times
an hour ago
- New York Times
New York Moves to Allow Terminally Ill People to Die on Their Own Terms
The New York State Senate approved a bill on Monday that would allow people facing terminal diagnoses to end their lives on their own terms, which the bill's proponents say would grant a measure of autonomy to New Yorkers in their final days. The bill, which passed the State Assembly earlier this year, will now head to the desk of Gov. Kathy Hochul, a Democrat, for her signature. It is unclear whether she plans to sign it; a spokesman for her office said she would review it. Eleven states and the District of Columbia have passed laws permitting so-called medical aid in dying. The practice is also available in several European countries and in Canada, which recently broadened its criteria to extend the option to people with incurable chronic illnesses and disabilities. The bill in New York is written more narrowly and would apply only to people who have an incurable and irreversible illness, with six months or less to live. Proponents say that distinction is key. 'It isn't about ending a person's life, but shortening their death,' said State Senator Brad Hoylman-Sigal, a Manhattan Democrat and one of the sponsors of the bill. It passed on Monday night by a vote of 35 to 27, mostly along partisan lines. He framed the measure as a statement of New York's values, citing efforts by Republicans to increase governmental control over people's bodies, including by restricting gender-affirming care and abortion. Want all of The Times? Subscribe.
Associated Press
an hour ago
- Associated Press
New York lawmakers approve bill that would allow medically assisted suicide for the terminally ill
ALBANY, N.Y. (AP) — Terminally ill New Yorkers would have the legal ability to end their own lives with pharmaceutical drugs under a bill passed Monday in the state Legislature. The proposal, which now moves to the governor's office, would allow a person with an incurable illness to be prescribed life-ending drugs if he or she requests the medication and gets approval from two physicians. A spokesperson for New York Gov. Kathy Hochul said she would review the legislation. The New York Senate gave final approval to the bill Monday night after hours of debate during which supporters said it would let terminally ill people die on their own terms. 'It's not about hastening death, but ending suffering,' said state Sen. Brad Hoylman-Sigal, a Democrat who sponsored the proposal. Opponents have argued the state should instead improve end-of-life medical care or have objected on religious grounds. 'We should not be in the business of state-authorized suicide,' said state Sen. George Borrello, a Republican. The state Assembly passed the measure in late April. The proposal requires that a terminally ill person who is expected to die within six month make a written request for the drugs. Two witnesses would have sign the request to ensure that the patient is not being coerced. The request would then have to be approved by the person's attending physician as well as a consulting physician. The legislation was first introduced in 2016, Hoylman-Sigal said, though it has stalled year after year in the New York statehouse. Dennis Poust, executive director of the New York State Catholic Conference, which has opposed the measure, said 'This is a dark day for New York State.' Eleven other states and Washington, D.C., have laws allowing medically assisted suicide, according to Compassion & Choices, an advocacy organization that backs the policy. Corinne Carey, the group's local campaign director, said lawmakers had 'recognized how important it is to give terminally ill New Yorkers the autonomy they deserve over their own end-of-life experiences.' 'The option of medical aid in dying provides comfort, allowing those who are dying to live their time more fully and peacefully until the end,' said Carey.
